Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTAC outpatient anti-coronavirus hIVIG trial
2021-001663-24Phase 3Active
- Sponsor
- University of Minnesota
- Start
- Jul 2021
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of CoviGlobulin in coronavirus disease 2019 (COVID-19), sponsored by University of Minnesota. Started Jul 2021; status: active.
02
Drugs
CoviGlobulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-001663-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001663-24.